Here is an interesting article from the NY Times about an ADHD medication, Vyvanse, that was recently approved for Binge Eating Disorder. Binge Eating Disorder is a relatively new diagnosis, though it has been identified in individuals for some time. Basically, we finally have a formal name for a condition that has been around for a while.
This article brings in to question some of the practices of pharmaceutical companies, as well as the FDA itself. Let us know your thoughts.
You can find the article here: http://www.nytimes.com/2015/02/25/business/shire-maker-of-binge-eating-drug-vyvanse-first-marketed-the-disease.html?_r=0